
Science Resources RSS Feeds
|
 |
 |
 |
Scientists develop new treatments for Alzheimer's disease
October 27, 2006
Scientists at the University of Liverpool have created a new chemical compound that could be developed into a drug treatment for Alzheimer's disease. The research team has used a family of long chain sugars called Heparan Sulphates (HS), found on nearly every cell of the body, to produce a new compound that can prevent the formation of clumps of small proteins that form in the brain. These clumps or 'plaques' disrupt the normal function of cells leading to progressive memory loss which is characteristic of Alzheimer's disease.
The clumps are formed from a small protein fragment called Amyloid-beta (A-beta) peptide released from its 'parent' protein-amyloid precursor protein (APP). This process requires the action of an enzyme called beta-secetase (BACE), which is critical in clipping up the APP to form the smaller A-beta fragments.
Professor Jerry Turnbull and Dr Ed Yates, from the University's School of Biological Sciences, have discovered that the HS sugars may play a key role in limiting the development of Alzheimer's disease. The sugars stick to the BACE enzyme and reduce its ability to 'clip' the A-beta peptide, thus controlling the amount of A-beta peptide available to form damaging plaques in brain tissue.
Professor Turnbull said: "We have developed a new class of compounds called 'engineered heparins' that could possibly be developed into drugs to stop A-beta peptides in the brain from forming and for the first time treat the underlying cause of Alzheimer's. The compound, based on the blood thinning drug, heparin, has modified chemical structures designed to optimise their desired activities and reduce potential side effects.
"The compounds work by blocking the beta-secretase enzyme, responsible for snipping proteins into smaller fragments. Despite its central importance to the disease, there are currently no drug treatments which target this enzyme because it has proved difficult to find inhibitors using traditional drug discovery approaches. The new compounds, based on the body's natural substances, may provide a novel route to effective treatments for this debilitating disease.\\\
University of Liverpool
|
 |
Related Alzheimers Disease Current Events and Alzheimers Disease News Articles Alzheimers Disease Current Events and Alzheimers Disease News RSS Cold sore virus might play role in Alzheimer's disease A gene known to be a major risk factor for Alzheimer's disease puts out the welcome mat for the virus that causes cold sores, allowing the virus to be more active in the brain compared to other forms of the gene.
Study offers window into human behavior, brain disease UCSF scientists have identified a cell population that is a primary target of the degenerative brain disease known as frontotemporal dementia, which is as common as Alzheimer's disease in patients who develop dementia before age 65.
New imaging compound might 'see' Alzheimer's earlier A new imaging molecule that can detect and map plaques and tangles in the brains of people with Alzheimer's disease could eventually lead to earlier diagnosis of the devastating disease, researchers at the University of California, Los Angeles report in the Dec. 21, 2006, issue of the New England Journal of Medicine.
Testosterone therapy may prevent Alzheimer's disease Researchers at the University of Southern California have discovered a direct link between loss of testosterone and the development of an Alzheimer's-like disease in mice. They also discovered that testosterone treatment slows progression of the disease.
Androgen therapy may slow progress of Alzheimer's disease Experiments on mouse models of Alzheimer's disease (AD) suggest that treatment with male sex hormones might slow its progression.
Protein 'fingerprint' in spinal fluid could spot Alzheimer's disease Scientists collaborating at Cornell University in Ithaca and Weill Cornell Medical College in New York City have identified a panel of 23 protein biomarkers in cerebrospinal fluid that acts as a neurochemical "fingerprint," which doctors might use someday to identify patients living with Alzheimer's disease.
Study shows cats can succumb to feline Alzheimer's disease Ageing cats can develop a feline form of Alzheimer's disease, a new study reveals. Scientists at the Universities of Edinburgh, St Andrews, Bristol and California have identified a key protein which can build up in the nerve cells of a cat's brain and cause mental deterioration.
Scientists develop a new way to target Alzheimer's disease The pathological embrace between two proteins plays a key role in the development of Alzheimer's disease by triggering the formation of neuron-killing plaques of amyloid beta protein. Now a group of scientists at NYU School of Medicine have devised a way to reduce amyloid beta deposition by interfering with the deadly embrace of these proteins.
Complaints About Memory Are Associated With Alzheimer-Related Brain Damage Researchers at Rush University Medical Center found that having complaints about memory problems is associated with changes in the brain related to Alzheimer's disease. They reported their findings in the November 2006 issue of Neurology.
More insight into Alzheimer's disease with Stanford discovery of possible cause A peacekeeper in the body's defenses against infection may hold the key to understanding-and eventually treating-Alzheimer's disease. Researchers at the Stanford University School of Medicine discovered that when a molecule responsible for dialing down the immune system malfunctions in the brain cells of mice, the rodents develop symptoms of the degenerative brain disease. More Alzheimers Disease Current Events and Alzheimers Disease News Articles
|
 |

|
A Caregiver's Guide to Alzheimer's Disease: 300 Tips for Making Life Easier
by Patricia R. Callone (Editor)
Written for patients, their families, and caregivers, the practical information here will help readers understand what is physically happening to the brain so they can empower their own special skills and talents throughout the disease process. The book is divided into three sections that correspond to the progression of Alzheimer’s, and the unique challenges encountered at each stage. *Section A: The four stages of Alzheimer's with hundreds of practical tips for coping at each level *Section B: Q&A for caregivers, including legal and financial issues, medication, helping children understand, handling the holidays and more. *Section C: Resources and websites. This is an essential book for all those who want to focus on the capabilities that...
|

|
Learning to Speak Alzheimer's: A Groundbreaking Approach for Everyone Dealing with the Disease
by Joanne Koenig Coste (Author), Robert Butler (Foreword)
More than four million Americans suffer from Alzheimer’s, and as many as twenty million have close relatives or friends with the disease. Revolutionizing the way we perceive and live with Alzheimer’s, Joanne Koenig Coste offers a practical approach to the emotional well-being of both patients and caregivers that emphasizes relating to patients in their own reality. Her accessible and comprehensive method, which she calls habilitation, works to enhance communication between carepartners and patients and has proven successful with thousands of people living with dementia. Learning to Speak Alzheimer’s also offers hundreds of practical tips, including how to · cope with the diagnosis and adjust to the disease’s progression · help the patient talk about the illness · face the...
|

|
Alzheimer's Disease: Facing the Facts
Starring: n/a Directed By: n/a
Studio: Wgbh Wholesale Release Date: 03/17/2009 Run time: 56 minutes
|

|
Alzheimer's from the Inside Out
by Richard Taylor (Author)
Receiving a diagnosis of Alzheimer’s disease profoundly alters lives and creates endless uncertainty about the future. How does a person cope with such a life-changing discovery? What are the hopes and fears of someone living with this disease? How does he want to be treated? How does he feel as the disease alters his brain, his relationships, and ultimately himself? Richard Taylor provides illuminating responses to these and many other questions in this collection of provocative essays. Diagnosed with Alzheimer’s disease at age 61, the former psychologist courageously shares an account of his slow transformation and deterioration and the growing division between his world and the world of others. With poignant clarity, candor, and even occasional humor, more than...
|

|
The 36-Hour Day: A Family Guide to Caring for People with Alzheimer Disease, Other Dementias, and Memory Loss in Later Life, 4th Edition
by Nancy L. Mace (Author), Peter V. Rabins (Author)
Revised in 2006 for its twenty-fifth anniversary, this best-selling book is the "bible" for families caring for people with Alzheimer disease, offering comfort and support to millions worldwide. In addition to the practical and compassionate guidance that have made The 36-Hour Day invaluable to caregivers, the fourth edition is the only edition currently available that includes new information on medical research and the delivery of care. The new edition includes: -new information on diagnostic evaluation-resources for families and adult children who care for people with dementia-updated legal and financial information-the latest information on nursing homes and other communal living arrangements-new information on research, medications, and the biological causes and...
|

|
The Myth of Alzheimer's: What You Aren't Being Told About Today's Most Dreaded Diagnosis
by Peter J. Whitehouse M.D. (Author), Daniel George M.Sc. (Author)
Dr. Peter Whitehouse will transform the way we think about Alzheimer’s disease. In this provocative and ground-breaking book he challenges the conventional wisdom about memory loss and cognitive impairment; questions the current treatment for Alzheimer’s disease; and provides a new approach to understanding and rethinking everything we thought we knew about brain aging. The Myth of Alzheimer’s provides welcome answers to the questions that millions of people diagnosed with Alzheimer’s disease – and their families – are eager to know: Is Alzheimer’s a disease? What is the difference between a naturally aging brain and an Alzheimer’s brain? How effective are the current drugs for AD? Are they worth the money we spend on them? What kind of hope does...
|

|
Plain Talk about Alzheimer's Disease
Starring: - Directed By: -
Ask anyone who has been through it: seeing a friend or loved one deteriorate with Alzheimer's is one of the most painful experiences to behold. Here is help in understanding what is happening. Kimberly R. Kelly talks about Alzheimer's and Related Dementia followed by the most feared and little known aspects of Alzheimer's Wandering. Kim has a wonderful ability to explain in a simple and understandable way the effects Alzheimer's has on a person's brain and behavior. She also explains what current drug therapies are being used to treat patients. Kim is the founder and executive director of Project Far from Home, an Alzheimer's education program designed for law enforcement, fire, EMS, and search and rescue. She was awarded the President's Volunteer Service Award from President...
|

|
The Alzheimer's Action Plan: What You Need to Know--and What You Can Do--about Memory Problems, from Prevention to Early Intervention and Care
by P. Murali Doraiswamy M.D. (Author), Lisa P. Gwyther M.S.W. (Author), Tina Adler (Author)
What would you do if your mother was having memory problems?
Five million Americans have Alzheimer’s disease, with a new diagnosis being made every seventy-two seconds, with millions more at risk. Although experts agree that early diagnosis and treatment are essential, families don’t know where to turn for authoritative, state-of-the-art advice and answers to all of their questions.
Now, combining the insights of a world-class physician and an award-winning social worker, this ground-breaking book tells you everything you need to know, including: The best tests to determine if this is—or is not—Alzheimer’s disease...
|

|
Alzheimer's Early Stages: First Steps for Family, Friends and Caregivers
by Daniel Kuhn (Author), M.D. David A. Bennett (Foreword)
This edition includes the latest information on Alzheimer’s risk factors, treatments, and prevention, as well as a new chapter, "Voices of Experience," composed of reflections by family members. It also provides information about new drugs approved since 1999 and the federal government’s decision to cover counseling and other health-related services through Medicare.
|

|
The Family Guide to Alzheimer's Disease: 5 Volume Set
Starring: Leeza Gibbons Directed By: Mike Merryman
For many families, Alzheimer's means a gradually diminishing quality of life both for the sufferer and caregivers. All too often, the disease has led to isolation and even a certain social stigma. It can impose psychological and emotional burdens just as heavy as the physical one. The Family Guide to Alzheimer's Disease was created to help families understand what to expect; deal effectively with the challenge of this disease; help their loved ones meet each day more successfully; and enhance the quality of life for all involved.
|
|